Cem Mirili

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Neoadjuvant Chemotherapy

Transcription Factor

Sentinel Lymph Node

Top Venues

International journal of clinical oncology

European journal of breast health

Journal of gastrointestinal cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Mahmut Buyuksimsek, Mehmet Mutlu Kidi, Ali Oğul, Cem Mirili, Semra Paydaş
The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin Regimen. Journal of gastrointestinal cancer 52 (1) (2021)
Mahmut Buyuksimsek, Ali Oğul, Cem Mirili, Semra Paydaş
Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy. European journal of breast health 16 (4) (2020)
Cem Mirili, Ali Yılmaz, Serkan Demirkan, Mehmet Bilici, Salim Basol Tekin
Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. International journal of clinical oncology 24 (10) (2019)
Cem Mirili, Isa Burak Guney, Semra Paydas, Gulsah Seydaoglu, Tuba Korkmaz Kapukaya, Ali Ogul, Serkan Gokcay, Mahmut Buyuksimsek, Abdullah Evren Yetisir, Bilgin Karaalioglu, Mert Tohumcuoglu
Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC). International journal of clinical oncology 24 (2) (2018)